Medicaid Drug Rebate Program Active Pharmaceutical Products

Quarterly snapshots of active drugs reported by manufacturers under the Medicaid Drug Rebate Program. The data includes product identifiers, FDA approval dates, market entry dates, and indicators for innovator status, prescription type, and therapeutic equivalency. It is published by the U.S. Department of Health & Human Services.

Use Cases

• Analyze the distribution of innovator versus non-innovator drugs using the innovator indicator field.
• Track market entry timelines by comparing FDA approval date and the date the drug entered the market.
• Segment the pharmaceutical market by prescription type using the OTC/prescription indicator.
• Study therapeutic classifications using the FDA therapeutic equivalency code for formulary management.

Strengths

• Data is provided by the authoritative U.S. Department of Health & Human Services.
• Includes key regulatory and market dates such as FDA approval date and market entry date.
• Contains specific drug classification indicators like innovator status and prescription type.

Limitations

• The row count and total number of features are unknown, limiting assessment of scale and completeness.
• Data is a quarterly snapshot and is not updated for changes within that quarter, potentially missing real-time status.
• The absence of sample data or a column list prevents verification of data structure and quality.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by participating drug manufacturers under the Medicaid Drug Rebate Program.

Freshness

Quarterly snapshots; last updated 2026-02-25.

Geography

United States